Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
Go back to Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026| (NASDAQ: IMVT) | Delayed: 37.59 +0.23 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.36 | 52 Week High | $ | |||
| Open | $37.25 | 52 Week Low | $ | |||
| Day High | $37.77 | P/E | N/A | |||
| Day Low | $37.00 | EPS | $ | |||
| Volume | 85,833 | |||||
| (NASDAQ: ROIV) | Delayed: 40.89 +0.07 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.82 | 52 Week High | $ | |||
| Open | $40.64 | 52 Week Low | $ | |||
| Day High | $41.33 | P/E | N/A | |||
| Day Low | $40.44 | EPS | $ | |||
| Volume | 508,740 | |||||
